FDA approved a new generic of Novartis’ Diovan (valsartan) amid a shortage of the blood pressure drug.
Nasal spray offers promise for treatment-resistant depression, but proceed with caution.
FDA approved first interoperable insulin pump, as well as the only FDA-approved drug for patients with a neglected tropical disease.
FDA approved the first generic of a popular inhaler to treat asthma and chronic obstructive pulmonary disease
FDA approves cabozantinib to treat patients with hepatocellular carcinoma, a community in need of new therapeutic options.
FDA cleared the first generic tablet version of a top-selling epilepsy drug.
FDA approved a record number of novel treatments in 2018.
Two new therapies approved by FDA signal significant advancement in treating rare blood diseases.
A new non-small cell lung cancer (NSCLC) treatment is available to healthcare providers immediately.
FDA approved the first biosimilar to rituximab (Rituxan, Genentech) to treat non-Hodgkin lymphoma.